Several factors go into selecting a PGx gene panel test including which genes are on the panel, the scope of variants detected, as well as cost, insurance reimbursement, turn-around-time, ease of use of the report, integration of results into the EHR and other factors. In this white paper, we dig into commercially available comprehensive PGx tests and compare and evaluate the clinical validity of the genes analyzed.
Want more on Pharmacogenomics?
Do you find yourself still asking the following questions about pharmacogenomics:
- How can genetic testing can be used to reduce side effects and improve efficacy of prescription medications?
- Which pharmacogenomic test should I order?
- Does insurance cover pharmacogenomic testing?
If you are interested in learning more about pharmacogenomics, check out our online course, Pharmacogenomics in Practice. Join Dr. Jeanette McCarthy, a genome scientist and leading educator in the field of precision medicine, to learn how to implement pharmacogenomic testing in your practice.
Jeanette McCarthy is a genome scientist and leading educator in the field of precision medicine. She spent the early part of her career in industry at Millennium Pharmaceuticals before transitioning to academia. She currently holds adjunct faculty positions at Duke University and UCSF and teaches Genomic and Precision Medicine in the UC system and online. In 2014 she helped launch the first consumer-facing magazine in this field, Genome, where she served as editor-in-chief. She has been designing and delivering custom workshops and courses to international audiences of health care providers, consumers and stakeholders for years and co-authored Precision Medicine: A Guide to Genomics in Clinical Practice. (2016, McGraw Hill Education).